Indo Us Bio-Tech Limited

BSE:541304 Stock Report

Market Cap: ₹5.5b

Indo Us Bio-Tech Past Earnings Performance

Past criteria checks 5/6

Indo Us Bio-Tech has been growing earnings at an average annual rate of 28.3%, while the Food industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 17.6% per year. Indo Us Bio-Tech's return on equity is 16.7%, and it has net margins of 13.8%.

Key information

28.3%

Earnings growth rate

19.2%

EPS growth rate

Food Industry Growth17.6%
Revenue growth rate17.6%
Return on equity16.7%
Net Margin13.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Indo Us Bio-Tech makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:541304 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24848117380
30 Jun 2478490390
31 Mar 2472883400
31 Dec 23752105320
30 Sep 2368682330
30 Jun 2366881320
31 Mar 2361772310
31 Dec 2255958210
30 Sep 2252757290
30 Jun 2251454270
31 Mar 2250151260
31 Dec 2149455210
30 Sep 2148859160
30 Jun 2144454160
31 Mar 2140149160
31 Dec 2039439170
30 Sep 2038628170
30 Jun 2039227170
31 Mar 2039825180
31 Dec 193762470
30 Sep 193542280
30 Jun 193542290
31 Mar 193532180
31 Mar 182941460
31 Mar 17245470
31 Mar 16190450
31 Mar 15196550
31 Mar 14148340

Quality Earnings: 541304 has high quality earnings.

Growing Profit Margin: 541304's current net profit margins (13.8%) are higher than last year (11.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 541304's earnings have grown significantly by 28.3% per year over the past 5 years.

Accelerating Growth: 541304's earnings growth over the past year (43.4%) exceeds its 5-year average (28.3% per year).

Earnings vs Industry: 541304 earnings growth over the past year (43.4%) exceeded the Food industry 16.8%.

Return on Equity

High ROE: 541304's Return on Equity (16.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:19
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indo Us Bio-Tech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution